Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients-Reference-Cited by-同舟云学术

Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients

Published:2010-03-24 Issue:12 Volume:116 Page:2913-2921
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ferroni Patrizia,Roselli Mario,Spila Antonella,D'Alessandro Roberta,Portarena Ilaria,Mariotti Sabrina,Palmirotta Raffaele,Buonomo Oreste,Petrella Giuseppe,Guadagni Fiorella

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference22 articles.

1. Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis;Gout;Clin Exp Metastasis.,2008

2. Mechanisms by which E-selectin regulates diapedesis of colon cancer cells under flow conditions;Tremblay;Cancer Res.,2008

3. Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis;Khatib;Am J Pathol.,2005

4. The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation;Auguste;Am J Pathol.,2007

5. Influence of TNFA on the formation of liver metastases in a syngenic mouse model;Sturm;Int J Cancer.,2003

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vacuum-assisted Evacuation (VAEv) of Symptomatic and/or Voluminous Breast Haematomas Following Surgeries and Percutaneous Procedures;Anticancer Research;2023-04-25

2. AUTOIMMUNE MASTITIS AS A CLINICAL MANIFESTATION OF BEHcET'S DISEASE: A CASE REPORT AND A SYSTEMATIC LITERATURE REVIEW;WORLD CANCER RES J;2023

3. From Patient Reported Outcome Measure (PROM) to Environment Related Outcome Measure (EROM): Towards “Green Breast Surgery”;In Vivo;2023

4. Awake Breast Surgery: A Systematic Review;In Vivo;2023

5. Socioeconomic Impact of OncotypeDX on Breast Cancer Treatment: Preliminary Results;In Vivo;2023